This topic contains a solution. Click here to go to the answer

Author Question: Define the alanine shunt and in what disease it is used. ... (Read 6 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
Define the alanine shunt and in what disease it is used.

Question 2

Identify goals and tasks for the resolving phase for each of the three motivational levels in the motivational nutrition counseling algorithm.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

smrerig

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

The alanine shunt is a process that allows glucose production from protein sources through conversion of the amino acid alanine to pyruvate to glucose in the liver; the glucose produced can then be used in the muscle to generate additional alanine. In glycogen storage disease type III, protein is used as an alternative source of glucose production, via the alanine shunt, since the use of carbohydrates is compromised due to the glycogen debranching enzyme malfunction.

Answer to Question 2

1) Not ready is the first level and the goal is to raise doubt about the present dietary behavior and the major task is to inform and facilitate contemplation of change.
2) Unsure is the second level and the goal is to build confidence and increase motivation to change dietary behavior and the major task is to explore and resolve ambivalence.
3) Ready is the third level and the goal is to negotiate a specific plan of action and the major task is to facilitate decision making.




james9437

  • Member
  • Posts: 568
Reply 2 on: Aug 20, 2018
Thanks for the timely response, appreciate it


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

For a complete list of videos, visit our video library